Latest Astec Industries (ASTE) Headlines Is Luxfer

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Astec Industries (ASTE) Headlines

Is Luxfer Holdings (LXFR) Poised to Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 9:20AM CDT
Luxfer Holdings is set to report fourth-quarter 2013 results on Mar 13, after the market closes.

Astec Industries (ASTE) Jumps: Stock Rises 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 8:18AM CDT
Astec Industries, Inc. (ASTE) was a big mover last session, as the company saw its shares rise by roughly 7% on the day.

Why Astec (ASTE) Stock Might be a Great Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 7:54AM CDT
Astec is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. It has a Zacks Industry Rank of 26 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Astec Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 11:58AM CDT
Astec Industries shares attained a 52-week high of $41.68 during intraday trading on Mar 7.

Upgrade Alert for Astec Industries (ASTE)
Comtex SmarTrend(R) - Mon Mar 10, 8:35AM CDT
Astec Industries (NASDAQ:ASTE) was upgraded from Neutral to Outperform at RW Baird today. The stock closed yesterday at $41.34 on volume of 59,000 shares, below average daily volume of 104,000. Astec Industries, Inc. designs, engineers, manufactures, markets, and finances equipment and components used primarily in road building and related construction activities. The Company's products are used in each phase of road building, from quarrying and crushing the aggregate to application of the road surface.

Joy Global Lags on Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 12:20PM CST
Joy Global's earnings per share in fiscal first quarter 2014 were lower than the Zacks Consensus Estimate.

Tel Aviv Stock Exchange Corporate Fact Sheet February 2014
PR Newswire - Tue Mar 04, 8:46AM CST
Fast Facts

Astec Rises on Q4 Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 27, 9:30AM CST
Astec's fourth-quarter earnings surpassed the Zacks Consensus Estimate while revenues missed the same.

Astec Industries, Inc. to Present at AEM Investor's Conference at Conexpo -- CON/AGG 2014
GlobeNewswire - Wed Feb 26, 7:42AM CST
Astec Industries, Inc. (Nasdaq:ASTE) announces today that it will participate in the AEM Investor's Conference in Las Vegas, Nevada on Wednesday, March 5, 2014. Benjamin G. Brock, President and Chief Executive Officer and Stephen C. Anderson, Vice President of Administration and Director of Investor Relations will attend the conference.

Astec Industries Reports Fourth Quarter and 2013 Results
GlobeNewswire - Tue Feb 25, 6:14AM CST
Astec Industries, Inc. (Nasdaq:ASTE) today reported results for their fourth quarter and year ended December 31, 2013. Net sales for the fourth quarter of 2013 were $223.9 million compared to $227.6 million for the fourth quarter of 2012, a 2% decrease. Earnings from continuing operations for the fourth quarter of 2013 were $8.3 million or $0.36 per diluted share compared to $5.5 million or $0.24 per diluted share in the fourth quarter of 2012, an increase of 51%.

Don't Just Look! Ride and Drive Chrysler Group Vehicles at the 2014 Dallas/Fort Worth Auto Show
PR Newswire - Tue Feb 18, 8:30AM CST
-- Ram Test Track is the first indoor test track at the DFW Auto Show

Astec Industries, Inc. (NASDAQ:ASTE) Announces Its Fourth Quarter and 2013 Conference Call February 25, 2014 at 10:00 A.M. Eastern Time
GlobeNewswire - Tue Feb 18, 8:00AM CST
You are invited by Astec Industries, Inc. (Nasdaq:ASTE) to participate in a conference call to review its Fourth Quarter and 2013 financial results.

Westbury Bancorp, Inc. Appoints Chief Operating Officer And New Director
PR Newswire - Fri Jan 17, 12:00PM CST
Westbury Bancorp, Inc. (NASDAQ: WBB). Westbury Bancorp, Inc. (the "Company"), the holding company for Westbury Bank (the "Bank") announced today that the Boards of Directors of the Company and the Bank have appointed Greg J. Remus, 44, as the Chief Operating Officer of the Company and the Bank. Mr. Remus has been employed by Westbury Bank since 2009, and is currently serving as Senior Vice President of Lending, and has over 20 years of experience in the financial services industry. He previously served as Vice President of Commercial Real Estate for M&I Bank from 2004-2009 and, before that, as Vice President Commercial Lending of ISB Community Bank. Mr. Remus holds a degree in mathematics from the University of Wisconsin. His responsibilities include general oversight of our commercial business, multi-family and commercial real estate loan portfolio, including credit quality, underwriting, administration, collections, loan yield pricing and portfolio growth. Mr. Remus will continue to serve as Senior Vice President of Lending of the Bank. In addition, in his new role, Mr. Remus will be focused on the Bank's continuing commitment to transform itself into a community-focused commercial bank. Ray Lipman, President and Chief Executive Officer of the Company and the Bank said, "Greg's leadership skills will be very important to implementing the Bank's strategic growth initiatives and moving forward the Bank's overall financial performance. This appointment will allow me to continue my focus on long term strategic matters and capital management strategies of the Bank and the Company for the next several years while Greg will be responsible for all day to day commercial and retail banking functions such as lending, deposit gathering and wealth management functions."

Strategy To YieldBoost Astec Industries To 7.5% Using Options
StockOptionsChannel.com - Fri Jan 03, 11:27AM CST
Shareholders of Astec Industries, Inc. looking to boost their income beyond the stock's 1.1% annualized dividend yield can sell the June covered call at the $40 strike and collect the premium based on the $1.10 bid, which annualizes to an additional...

Astec Down to Underperform - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 25, 1:40PM CST
We have downgraded our recommendation on Astec to Underperform.

HEES Gains on Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 06, 1:20PM CST
Shares of H&E Equipment Services jumped 23% since it reported Q3 adjusted earnings on Nov 1.

Astec Industries, Inc. to Present at Robert W. Baird's 2013 Industrial Conference
GlobeNewswire - Fri Nov 01, 6:00AM CDT
Astec Industries, Inc. (Nasdaq:ASTE) announces today that it will participate in the Robert W. Baird 2013 Industrial Conference in Chicago, Illinois on Tuesday, November 5, 2013. Benjamin G. Brock, Group President - Asphalt, Richard J. Dorris, Group President - Energy and Stephen C. Anderson, Vice President of Administration and Director of Investor Relations will attend the conference.

Terex Gains on Solid Q3 Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 28, 10:58AM CDT
Terex's third quarter earnings beat the Zacks Consensus Estimate.

Manitowoc Shares Up on Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 28, 7:00AM CDT
Shares of Manitowoc gained 4% after reporting upbeat third-quarter 2013 results on Oct 24.

Zacks #5 Rank Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 24, 7:30AM CDT
Here are 5 stocks added to the Zacks #5 Rank ("strong sell") List for Thursday

Astec Industries Inc. (ASTE) Stock Research Links

ASTE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 312

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 350

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 330

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 638

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 342

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 479

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 389

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 122

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 182

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

HALiXPEDITE Revolutionizes Biologics Therapy Development Process

Updated Category News Views 147

HALiXPEDITE: Transforming the Future of Biologics Development HALIX, a prominent global healthcare Contract Development and Manufacturing Organization (CDMO), recently unveiled its innovative platform, HALiXPEDITE, at a notable conference. This platform is specifically designed to expedite the development of biologics therapies, focusing on a streamlined approach to...

Continue Reading
Day One Biopharmaceuticals to Share Q3 2025 Insights

Updated Category News Views 170

Day One Biopharmaceuticals to Present Q3 2025 Financial Results In a busy season for the biopharmaceutical industry, Day One Biopharmaceuticals (Nasdaq: DAWN) has announced it will host a live conference call and webcast aimed at reporting its financial results and outlining corporate progress for the third quarter of 2025. Conference Call Details The event is scheduled...

Continue Reading
Leica Biosystems Promotes DICOM Standards for Digital Pathology

Updated Category News Views 114

Leica Biosystems Promotes DICOM Standards for Digital Pathology Leica Biosystems, a prominent figure in anatomic pathology, has recently made waves in the medical field with a bold new initiative. By announcing the non-enforcement of their Digital Pathology DICOM (Digital Imaging and Communications in Medicine) patent portfolio, they aim to boost the implementation of...

Continue Reading
LYNPARZA: A Breakthrough in Early Breast Cancer Treatments

Updated Category News Views 288

Significant Survival Benefits with LYNPARZA in Breast Cancer Recent findings from the OlympiA Phase III trial bring exciting news for patients battling early breast cancer. AstraZeneca and Merck & Co., Inc.'s LYNPARZA (olaparib) has showcased profound improvements in survival rates among patients with germline BRCA-mutated HER2-negative high-risk early breast cancer. This...

Continue Reading
EuroDry Limited's Stock Experiences Volatility Amid Challenges

Updated Category News Views 229

EuroDry Limited Faces Stock Turmoil EuroDry Ltd. (NASDAQ: EDRY), a leading provider in drybulk shipping, has recently encountered a tumultuous phase, with its stock reaching a noteworthy low at $14.1. This decline marks a significant reflection on the year's challenges the company has faced, indicated by a -14.71% change over the past year. Market Conditions and...

Continue Reading